Generics 106

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Isoniazid manufacturers

106 products found

Filters

106 products found

isoniazid

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #11480
The company was founded in the mid-1990s. It has been manufacturing pharmaceutical products and performing related pharmaceutical research and development. They are focused to provide quality products. They cater to all segments like anti allergies, dermatological products, cardiovascular products, etc.

Manufacturer usually replies in 4 days

isoniazid

Tablets 100 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Vietnam
Registered in
Bulgaria
Available for
Licensing with supply
Manufacturer #15813
A pharmaceutically oriented holding company that provides pharmacological solutions like never before. Their core business line entails dealing with the development, manufacturing, and distribution of pharmaceutical products, food supplements as well as cosmetics too.

Manufacturer usually replies in 12 days

isoniazid

Tablets 100 mg, 300 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
FDA, EU GMP
Unavailable markets
Serbia , Vietnam
Comments
Dossier availability depending on country legislation
Manufacturer #3436

A pharmaceutical manufacturer based in the EU that has been active in 70+ countries selling its products in Europe, the Middle East, LATAM, North America, Africa, and Asia for 60+ years. Key production lines are Rx, OTC, and nutraceuticals. The company's production lines are EU GMP-compliant. Main therapeutic areas include the cardiovascular system, CNS, and dermatology. Main dosage forms include solid, topical, and suppositories.

Manufacturer usually replies in 19 days

isoniazid

Syrup 50 mg/5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Comments
Reference product : Isotamine (Bausch Health)
Manufacturer #278

The company has become a prominent partner of the pharmacy community in North America, with the fastest rising market share among generic leaders. It can provide best-in-class supply reliability thanks to production capacity. In more than 50 countries, it's available locally or through corporate partnerships. R&D expenditures range from $40 million to $50 million per year. They are dedicated to maintaining a customer satisfaction rate of over 95% by continuously enhancing supply chain efficiency.

Manufacturer usually replies in 7 days

isoniazid

Tablets, orally disintegrating (ODT) 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #13225
It is an Indian manufacturer that is active in 40+ countries. They are in this line of business for 85+ years. The company has a more than $150 million turnover. The company manufactures and distributes more than 100 APIs and 200 formulations which is responsible for 25000+ SKUs. Quality control and quality assurance are one of the focus areas for the company.

Manufacturer usually replies in 3 days

isoniazid

Tablets 100mg, 200mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
MAs for sale
Georgia , Ukraine , Uzbekistan
Manufacturer #16118
The pharmaceutical plant follows the European standard throughout the plant. The core belief of the plant is to make sure that the customer receives the best pharmaceutical benefits as well as the intended patient care services.

Manufacturer usually replies in 7 days

isoniazid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21249

Manufacturer usually replies in 5 days

isoniazid + pyridoxine

Tablets 400 mg + 10 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Indonesia
GMP approvals
Indonesia
Manufacturer #20656

Manufacturer usually replies in 2 days

isoniazid + rifampicin + pyrazinamide

Tablets 60 mg+120 mg+300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

isoniazid + pyridoxine hydrochloride + rifampicin

Tablets 150 mg+10 mg+100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

isoniazid + rifampicin + ethambutol hydrochloride

Tablets 150 mg+75 mg+275 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19722

Manufacturer usually replies in 3 days

isoniazid

Tablets 100 mg, 300 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom
Manufacturer #12311

Manufacturer usually replies in 13 days

isoniazid

Oral suspension 50 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
United States
GMP approvals
FDA
Manufacturer #19566

isoniazid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

isoniazid

Tablets 100 mg, 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

isoniazid

Syrup 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

isoniazid

Injection 100 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20401

Manufacturer usually replies in 5 days

isoniazid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20259

Manufacturer usually replies in 9 days

isoniazid + rifampicin

Tablets 300 mg + 450 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

isoniazid

Tablets 300 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20087

Manufacturer usually replies in 8 days

Want to view all 106 products? Create your free account today!

Isoniazid Manufacturers

Isoniazid is a medication used to treat tuberculosis. Although it is sometimes available as a standalone medication, manufacturers of isoniazid more commonly use it alongside other active ingredients in pharmaceutical formulations, such as pyridoxine, rifampicin, pyrazinamide, rifampicin, ethambutol, and many others. Isoniazid suppliers market it in the form of 100mg tablets as well as 50mg/2ml injectable solution. In use for over 70 years, isoniazid is one of the drugs included in the WHO’s list of Essential Medicines that contains the most important medications recommended for a basic health system. The drug is available across multiple geographic markets, and, among the largest manufacturers of isoniazid medications are Amsal Chem, Resonance Specialties, Calyx Pharma, and Camus Pharma, whereas major suppliers include well-known companies Sanofi-Aventis, Novartis and GlaxoSmithKline. Generic versions of the drug are also available on the global pharmaceutical market.

How Does Isoniazid Work?

Isoniazid is a prodrug that needs bacterial catalase to activate it. Specifically, mycobacterial ferric KatG catalase-peroxidase reduction by hydrazine and reactivity with oxygen to create an oxyferrous enzyme complex are related with activation. Isoniazid, once activated, prevents the production of mycoloic acids, a crucial part of the bacterial cell membrane. Isoniazid is bacteriocidal against organisms of the Mycobacterium TB genus when used at therapeutic doses. By creating a covalent compound with the NAD cofactor, isoniazid prevent unethical InhA, the enoyl dehydrogenase from Mycobacterium TB. The sluggish, tightly-binding competitive blocker of InhA is the INH-NAD adduct. After oral administration, readily taken up; nevertheless, substantial first pass metabolism may occur. When isoniazid is taken with meals, its absorption and bioavailability are decreased. N-acetylisoniazid is biotransformed into isonicotinic acid and monoacetylhydrazine after being acetylated by N-acetyl transferase to N-acetylisoniazid. When the cytochrome P450 mixed oxidase system N-hydroxylates monoacetylhydrazine, a reactive intermediate metabolite is produced that is linked to hepatotoxicity. Genetics controls the rate of acetylation. Hepatic N-acetyltransferase is relatively inactive in slow acetylators.

Wholesale Price of Isoniazid

Prices of isoniazid vary, depending on whether it is a generic or trade name formulation and on manufacturer and supplier pricing. The retail prices per 100 (100mg) tablets of generic isoniazid are approximately 8,00 EUR to 10,00 EUR, whereas the equivalent amount of trade name isoniazid tablets cost 20,00 EUR. The costs of 100 (150mg + 100mg) Rifampicin/Isoniazid tablets, meanwhile, are around 15,00 EUR. Also the costs of Isoniazid vary depending on manufacturer and supplier pricing, whether it is a generic or trade name formulation, concentration of the active ingredient in the formulation. Isoniazid suppliers, on the whole, are in favor of patient aid initiatives. Isoniazid is available for sale from various Isoniazid vendors at multiple costs.

From Where to Get Isoniazid?

Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Isoniazid manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. PipelinePharma is the most reliable source for this medication. Finding an honest partner in our business is one of the significant challenges. To overcome this challenge and make one's life easier when looking for a direct manufacturer and supplier of Isoniazid, one can go to the Pipelinepharma website, which assists buyers in locating dependable manufacturers and suppliers of Isoniazid.

Navigating our Pharmaceutical Marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Isoniazid offerings can be narrowed down with filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for this substance manufacturer and Isoniazid suppliers that you are looking for. These also enable you to check the dossier status of this medicine and the GMP approvals of the different variants of Isoniazid. Also, each manufacturer or supplier product description contains essential information about this substance, including clinical data, stability zones, and countries in which Isoniazid is already registered. Manufacturers also have special delivery terms.

Establishing Commercial Ties

Suppose you are a pharmaceutical licensing company or a distributor. In that case, you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and order process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the Isoniazid suppliers. This way, the marketplace allows you as a distributor to skip the process of making a list of product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Isoniazid manufacturers for the quality of the pharmaceutical products' dossiers and protect against the risk of possible malpractices.